home > drugs a-z list > targretin gel (bexarotene gel) drug center > targretin gel (bexarotene gel) drug - patient how to take

Recommended Topic Related To:

Targretin Gel

Non-Hodgkin's lymphoma facts

  • NHL is a cancer that originates in the lymphatic system.
  • About 66,000 patients are diagnosed yearly, and approximately 18,000 patients die of NHL yearly in the U.S.
  • There are several subtypes of NHL, each requiring different treatments.
  • Symptoms include swollen lymph nodes, weight loss, fever, and night sweats.
  • NHL is staged on a 1-4 scale with A (no associated symptoms like fever, weight loss, or night sweats) and B subtypes.
  • Staging the cancer is important to determine treatment and predict the outcome of treatment.
  • Depending on the stage and type of NHL, treatment can include chemotherapy, biological therapy, stem cell transplant, and/or radiation therapy.

What is non-Hodgkin's lymphoma?

Non-Hodgkin's lymphoma is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most common cancer in the Unite...

Targretin Gel

font size

Targretin Gel Patient Information including How Should I Take

Who should not use bexarotene topical (Targretin Gel)?

Do not use bexarotene topical without first talking to your doctor if you are allergic to other retinoids such as isotretinoin (Accutane), acitretin (Soriatane), etretinate (Tegison), or tretinoin (Vesinoid).

Before using bexarotene topical, tell your doctor if you have kidney or liver disease. You may not be able to use bexarotene topical, or you may require a dosage adjustment or special monitoring during treatment.

Do not use bexarotene topical if you are pregnant or if you could become pregnant. Bexarotene topical is in the FDA pregnancy category X. This means that bexarotene topical will cause birth defects in an unborn baby. You must take a pregnancy test and have negative results within one week before starting treatment with bexarotene topical, and a pregnancy test should be repeated monthly during treatment. Bexarotene topical should be started on the second or third day of a normal menstrual period. Also, you will need to use two reliable forms of birth control at the same time for one month before starting treatment with bexarotene topical, during treatment with bexarotene topical, and for at least 1 month following the end of your treatment. If you become pregnant, stop using birth control, or miss your menstrual period, immediately stop using bexarotene topical and notify your doctor. Men using bexarotene topical with sexual partners who are pregnant, possibly pregnant, or who could become pregnant, must use condoms during sexual intercourse while using bexarotene topical and for at least one month after the last dose of bexarotene topical.

It is not known whether bexarotene topical passes into breast milk. Do not take bexarotene topical without first talking to your doctor if you are breast-feeding a baby.

How should I use bexarotene topical (Targretin Gel)?

Use bexarotene topical exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you.

Wash your hands with soap and water before and after applying this medication.

Apply enough gel to cover the affected area with a generous coating. Proper application should leave some gel visible on the surface of the lesion. Allow the gel to dry for 5 to 10 minutes before covering with clothing.

Do not use bandages, dressings, or other coverings, other than loose clothing, that block the flow of air to the treated area.

Do not apply bexarotene topical to unaffected skin. In addition, do not apply the gel near the eyes, mouth, nostrils, lips, vagina, tip of the penis, rectum, or anus. If you get medication on any of these areas, rinse it off with water.

Mild, non-deodorant soap is recommended for bathing or showering. Wait for 20 minutes after bathing or showering before applying bexarotene topical. Wait for at least 3 hours after applying bexarotene topical before bathing, showering, or swimming.

Bexarotene topical is initially applied once every other day for the first week. The application frequency is then usually increased at weekly intervals to once daily, then three times daily, and finally four times daily according to how well treatment is tolerated. If the affected area becomes irritated, the frequency of application can be reduced. If severe irritation occurs, application can be temporarily stopped for a few days until the irritation is reduced. Follow your doctor's instructions.

Avoid scratching the treated areas.

It may take many weeks of treatment to see the effects of this drug. Do not stop using bexarotene topical if you do not see results immediately. Treatment with bexarotene topical should continue for as long as beneficial effects are being obtained.

Store bexarotene topical at room temperature away from moisture and heat.

Related Drug Centers

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.